Navigation Links
Vanderbilt diabetes researchers track cells' ability to regenerate

Vanderbilt University scientists have found evidence that the insulin-secreting beta cells of the pancreas, which are either killed or become dysfunctional in the two main forms of diabetes, have the capacity to regenerate.

The surprising finding, posted online recently by Cell Metabolism, suggests that by understanding how regeneration occurs, scientists one day may be able to stop or reverse the rising tide of diabetes, which currently affects more than 8 percent of the U.S. population.

The study "provides clues to how we might learn what signals promote beta-cell regeneration in type 1 and type 2 diabetes," said Alvin Powers, M.D., the paper's senior author and director of the Vanderbilt Diabetes Center.

In the past three months, the Powers group at Vanderbilt, in four separate papers, has reported important findings about the "microenvironment" of the insulin-secreting beta cells and glucagon-secreting alpha cells, which are among four types of cells clustered in "islets" in the pancreas.

Both hormones are important in regulating blood glucose levels and ensuring that glucose is delivered to muscles and brain to be burned as fuel, and stored in the liver. Powers called the islets a "mini-organ" because they are highly vascularized and innervated, and exist within a specialized environment.

In type 1 diabetes, the beta cells are destroyed and glucose levels rise in the blood because not enough insulin is being produced. In type 2 diabetes, a frequent consequence of obesity, tissues become resistant to insulin, again causing blood glucose to rise. Beta cell function also becomes abnormal.

Marcela Brissova, Ph.D., research assistant professor of Medicine, was first or co-first author on three of the manuscripts. Chunhua Dai, M.D., research assistant professor of Medicine; and Kristie Aamodt and Rachel Reinert, Ph.D., students in the Vanderbilt M.D./Ph.D. program, were also among the first or co-first authors.

In two papers in the journal Diabetes and one each in Development and Cell Metabolism, the researchers described four main findings about islet vascularization and innervation:

First, vascular endothelial growth factor A (VEGF-A) is important for development of the islets' blood supply and for beta-cell proliferation. Blocking the growth factor early in development in a mouse model ultimately reduced beta-cell mass and insulin release and impaired glucose clearance from the bloodstream.

Other Vanderbilt scientists involved in this work were postdoctoral fellow Fong Cheng Pan, Ph.D., and Owen McGuinness, Ph.D., professor of Molecular Physiology and Biophysics.

Second, VEGF and other "signals" released by the endothelial cells lining islet blood vessels consequently stimulated growth of islet nerves in mice that connected to the brain.

"If the islets don't become vascularized properly, they don't become innervated properly," Brissova said. These signals also promote beta cell growth.

Other Vanderbilt scientists involved in this research were Ambra Pozzi, Ph.D., professor of Medicine, and Christopher V.E. Wright, D.Phil., Louise B. McGavock Professor, Department of Cell and Developmental Biology.

Third, VEGF-A was not involved when the beta-cell mass increased in an obese mouse model of type 2 diabetes in response to rising glucose levels.

Unlike tumors, which sprout new blood vessels as they grow, the beta-cell tissue increased its blood supply by dilating existing vessels.

Other Vanderbilt scientists involved in this research were Takamune Takahashi, M.D., Ph.D., associate professor of Medicine; Masakazu Shiota, DVM, Ph.D., associate professor of Molecular Physiology and Biophysics; and Eric H. Liu, M.D., assistant professor of Surgery.

Finally, too much VEGF-A can lead to beta cell death. But that sets up a regenerative microenvironment involving an interaction of vascular endothelial cells and macrophages which, in turn, leads to beta cell proliferation both in mice and human islets.

"That's very, very unusual because islet cells are like neurons; once they're dead, they don't usually regrow," Brissova said. "We think that the endothelial cells and macrophages which are recruited from the bone marrow create an environment that promotes the proliferation and regeneration of those beta cells."


Contact: Craig Boerner
Vanderbilt University Medical Center

Related biology news :

1. Yale Universitys Joan Steitz awarded 2012 Vanderbilt Prize
2. Vanderbilt-led team to develop microbrain to improve drug testing
3. How the science of deer hunting can help patients with diabetes
4. Managing Type 1 diabetes as an adolescent
5. Breast cancer gene could play critical role in obesity and diabetes
6. Study pinpoints protective mutations for type 2 diabetes
7. Inside out at the 2014 AAAS meeting: The impact of gut flora on diabetes and obesity
8. A role of glucose tolerance could make the adaptor protein p66Shc a new target for cancer and diabetes
9. Seven new genetic regions linked to type 2 diabetes
10. New molecule protects brain from detrimental effects linked to diabetes and high blood sugar
11. Ingredients in chocolate, tea and berries could guard against diabetes
Post Your Comments:
Related Image:
Vanderbilt diabetes researchers track cells' ability to regenerate
(Date:10/1/2015)... Oct. 1, 2015  Biometrics includes diverse set ... body characteristics, such as fingerprints, eye retinas, facial ... of biometrics technology has been constantly increasing in ... five years. In addition to the most prominent ... recognition, other means of biometric authentication are rapidly ...
(Date:9/29/2015)... , Sept. 29, 2015 News ... productivity while also saving energy , Minimized design ... Low Power Active Mode and embedded Fujitsu PalmSecure authentication ... Fujitsu today shows that good things come ... refreshed models to its enterprise desktop and mobile portfolio. ...
(Date:9/28/2015)... , September 28, 2015 ... expected to reach USD 12.03 billion by 2020, growing ... Technological advancements such as Backside Illumination (BSI) technique to ... over the forecast period.      (Logo: ... of the chip to reduce loss and, thus, reduce ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... PARK, N.J. and SAN DIEGO ... (BASF) and Mast Therapeutics, Inc. have agreed to collaborate ...  Currently, excipient-grade poloxamer 188 NF, marketed by BASF under ... used in a variety of pharmaceutical and biological applications, ... Poloxamer 188 is the starting material for Mast,s lead ...
(Date:10/13/2015)... , Oct. 13, 2015  Generex Biotechnology Corporation ( ... a non-binding Letter of Intent (LOI) with MediTemp Ltd. (MediTemp) ... a proprietary cooling technology designed to improve sperm quality in ... United States and three million men in ... 44 diagnosed as infertile.  For 42% of those men, the ...
(Date:10/13/2015)... ... , ... Proove Biosciences, a commercial and research leader ... Keck Medicine of the University of Southern California (USC) Pain Center to ... Research Clinical Objectives Linking Genotypic and Phenotypic Association with Pain Outcomes) is one ...
(Date:10/12/2015)... ... October 12, 2015 , ... Spirax Sarco, the leader in products ... CSM-C 600 compact clean steam generator . This unit is a skid ... of HTM2031, HTM2010, and EN285 standards. The CMS-C 600 generator can produce up ...
Breaking Biology Technology: